| 8:30 am | Welcome and Workshop Overview Planning Committee Co-Chairs:
|
| 9:00 am | Session 1: Multi-Level Approach to Understanding Biological Effectors and Social Determinants of Health Co-Moderators:
|
Overview of Health Disparities in Cancer
| |
Social Determinants of Health
| |
Overview of Biological Effectors of SDOH and Influence on Cancer Risk and Outcomes
|
| Panel Discussion Include speakers and
| |
| 10:30 am | Break |
| 10:45 am | Session 2: Review of Emerging Research on SDOH, Biological Pathways, and Cancer Outcomes Co-Moderators:
|
What Can the Health Care Sector Do About Social Conditions? The NASEM 5A Framework
| |
Allostatic Load and Breast Cancer: Tracing Social Determinant of Health Pathways
| |
An Interplay Between Social and Structural Determinants of Health and Stress in Cancer
| |
Emerging Genomic Pathways for Social Risk Exposure and Health Outcomes
| |
| Panel Discussion Include speakers and
| |
| 12:15 pm | Break |
| 1:15 pm | Session 3: Improving the Development and Validation of Biomarkers and Models Assessing the Effects of SDOH on Biological Pathways and Patient Outcomes Co-Moderators:
|
Global Networks Approaches
| |
Chronic Social Stressors and Breast Cancer Biology: Laboratory Insights
| |
Cancer Prevention and Biomarker Development
| |
The Biological Influences of Social Determinants of Health: Challenges, Surprises, and Complexities
| |
| Panel Discussion Include speakers and
| |
| 3:00 pm | Break |
| 3:15 pm | Session 4: Opportunities to Advance Progress on Biological Effectors of SDOH Research Co-Moderators:
|
Innovations in Population-Based Research Approaches to Advance Endometrial Cancer Equity: The Carolina Endometrial Cancer Study
|
SDOH at the Intersection of Cancer Health Equity Research and Real-World Evidence Generation
| |
Equity in Access to Oncology Biomarker Testing
| |
Minimizing the Impact of Biological and Social Drivers on Cancer Disparities: Prostate Cancer
| |
| Panel Discussion Include speakers and
| |
| 5:00 pm | Poster Session |
| 7:00 pm | Adjourn |
| 8:30 am | Session 5: Policy Opportunities to Address SDOH on Cancer Outcomes and Improve the Evidence Base on the Impact of SDOH on Biological Outcomes Co-Moderators:
|
National Policy
| |
Institutional Policy and Implementation
| |
Research Perspective
|
National Consumer Advocacy Perspective
| |
| Panel Discussion Include speakers and
| |
| 10:15 am | Break |
| 10:30 am | Session 6: Concluding Discussion and Next Steps Co-Moderators:
|
Panelists:
| |
| 11:30 am | Adjourn |
This page intentionally left blank.